COMMUNIQUÉS West-GlobeNewswire

Replimune Reports Financial Results for the First Fiscal Quarter, Ended June 30, and Provides Development and Corporate Update
30/08/2018
Completed initial public offering raising $111 million in total gross proceeds Entered into strategic collaboration with Regeneron Pharmaceuticals Signed lease for 63,000 sq. ft. manufacturing facility WOBURN, Mass., [...]
Catalyst Biosciences to Present at H.C. Wainwright & Co. 20th Annual Global Investment Conference
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]
IntelGenx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
SAINT LAURENT, Quebec, Aug. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that its Chief Financial Officer, Andre Godin, is scheduled [...]
Cutera Expands New truSculpt® iD Personalized Body Sculpting Solution to Europe
30/08/2018
BRISBANE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, today [...]
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that the company will participate in the following conferences in September: Citi’s 13 th [...]
SunGen Pharma Establishes Injectable Division and Forms Manufacturing Relationship with GRAM
30/08/2018
PRINCETON, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has entered into [...]
K2M Group Holdings, Inc. Announces Definitive Agreement To Be Acquired by Stryker Corporation
30/08/2018
LEESBURG, Va., Aug. 30, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
IRIDEX Cyclo G6™ Laser System for Glaucoma Treatment Used in Majority of Top U.S. Ophthalmology Hospitals
30/08/2018
Recent Study Published by U.S. News and World Report Highlighting the “Best Hospitals for Ophthalmology” Includes 35 IRIDEX Customers MOUNTAIN VIEW, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: [...]
Resverlogix Announces $26 Million Private Placement
30/08/2018
CALGARY, Alberta, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 10.4 million equity units at a price of [...]
Immune Design to Present at Upcoming September Investor Conferences
30/08/2018
SEATTLE and SOUTH SAN FRANCISCO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on novel therapies in oncology, today announced that senior management will present at [...]
Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
BOSTON, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
Zogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on Epileptology
30/08/2018
EMERYVILLE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced new [...]
Cutera introduit en Europe sa nouvelle solution truSculpt® iD de body sculpting personnalisé
30/08/2018
BRISBANE, Californie, 30 août 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. , (Nasdaq:CUTR) (« Cutera » ou la « Société ») un fournisseur leader de systèmes d'esthétique au laser, lumière et autres sources d'énergie pour les [...]
aTyr Pharma to Present at the Baird 2018 Global Healthcare Conference
30/08/2018
SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD
30/08/2018
MELBOURNE, Australia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce that CYP-001, its lead Cymerus™ mesenchymal [...]
Mustang Bio to Participate in September Investor Conferences
30/08/2018
NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech (NASDAQ: FBIO) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Tetra Bio-Pharma Adds New Marketing Vice-President
30/08/2018
ORLEANS, Ontario, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that Mr. Steeve Neron [...]
Tabula Rasa HealthCare’s CareKinesis Division to Provide Medication Risk Management and Pharmacy Services for Rocky Mountain PACE
30/08/2018
MOORESTOWN, N.J. and COLORADO SPRINGS, Colo., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (NASDAQ: TRHC) , a healthcare technology company advancing the field of medication safety, President and Chief [...]
Checkpoint Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
NEW YORK, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a Fortress Biotech (NASDAQ: FBIO) company, today announced that James F. Oliviero, President and Chief Executive [...]

Pages